Evidence map›Paper›PMID 40880781›Full record

ArticleChemical science2025

Ultrafast photophysics of a positive reversibly switchable fluorescent protein.

Anam Fatima, YongLe He, James N Iuliano, Gregory M Greetham, Partha Malakar, Christopher Hall, Helena A Woroniecka, Brian C Richardson, Jarrod B French, Andras Lukacs and 2 more

Abstract read
In one paragraph

Article in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anam FatimaSchool of Chemistry, University of East Anglia Norwich NR4 7TJ UK s.meech@uea.ac.uk.
YongLe HeDepartment of Chemistry, Stony Brook University Stony Brook New York 11794 USA peter.tonge@stonybrook.edu.ORCID https://orcid.org/0000-0001-7274-535X
James N IulianoDepartment of Chemistry, Stony Brook University Stony Brook New York 11794 USA peter.tonge@stonybrook.edu.ORCID https://orcid.org/0000-0003-1213-3292
Gregory M GreethamCentral Laser Facility, Research Complex at Harwell, Rutherford Appleton Laboratory Didcot OX11 0QX UK.
Partha MalakarCentral Laser Facility, Research Complex at Harwell, Rutherford Appleton Laboratory Didcot OX11 0QX UK.
Christopher HallSchool of Chemistry, University of East Anglia Norwich NR4 7TJ UK s.meech@uea.ac.uk.ORCID https://orcid.org/0000-0003-1267-1277
Helena A WoronieckaDepartment of Chemistry, Stony Brook University Stony Brook New York 11794 USA peter.tonge@stonybrook.edu.
Brian C RichardsonThe Hormel Institute, University of Minnesota Austin MN 55912 USA.
Jarrod B FrenchThe Hormel Institute, University of Minnesota Austin MN 55912 USA.
Andras LukacsDepartment of Biophysics, Medical School, University of Pecs 7624 Pecs Hungary Andras.lukacs@aok.pte.hu.ORCID https://orcid.org/0000-0001-8841-9823
Peter J TongeDepartment of Chemistry, Stony Brook University Stony Brook New York 11794 USA peter.tonge@stonybrook.edu.ORCID https://orcid.org/0000-0003-1606-3471
Stephen R MeechSchool of Chemistry, University of East Anglia Norwich NR4 7TJ UK s.meech@uea.ac.uk.ORCID https://orcid.org/0000-0001-5561-2782

Funding

X-ray Scattering Technology CoreP30GM133893 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI Sean McSweeney · 2019 to 2026
$38.6M
Chemical Biology Training InterfaceT32GM136572 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI ELIZABETH M BOON, Jessica Chuang Seeliger · 2020 to 2026
$2.9M
SBU Chemistry-Biology Interface Training ProgramT32GM092714 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI SAMPSON, NICOLE S, TONGE, PETER J · 2010 to 2019
$1.7M
Mechanism of Slow Onset Enzyme Inhibition and Translation to Time-Dependent Drug ActivityR35GM149297 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI PETER J TONGE · 2023 to 2026
$1.6M
NIGMS NIH HHS P30 GM133893NIGMS NIH HHS R35 GM149297NIGMS NIH HHS T32 GM092714NIGMS NIH HHS T32 GM136572
6 · The paper itself

Abstract

Reversibly switchable fluorescent proteins (rsFPs) are essential tools in super-resolution imaging. The mechanism operating in the widely applied negative switching rsFPs has been studied in detail. Much less attention has been paid to the positive switching rsFP variants, which offer the potential benefit of emissive states that do not photoswitch during measurement. Here we probe photochemical mechanism in all three photoactive states of the positive switching rsFP Kohinoor using a combination of ultrafast transient absorption, to probe chromophore population dynamics, and time resolved infrared, to access both chromophore populations and their effect on the surrounding protein matrix. We establish that none of the photochemical reactions are simple rate processes with transient absorption and transient IR data characterised by a common two component relaxation mechanism. Transient IR measurements reveal instantaneous coupling between the electronically excited chromophore and its protein environment, indicating that coupling arises from electrostatic or H-bonded interactions. In both on- and off-switching states the early phase of the excited state dynamics involve an initial relaxation in the perturbed protein environment, which leads to an intermediate state from which chromophore isomerization occurs. This result suggests that the protein dynamics play an active role in steering the excited state reaction, which is in-turn consistent with the known key role of the protein environment in tuning FP photophysics. Identifying and modifying the interactions between chromophore and protein will provide a means to optimise rsFP performance and thus a basis for development of improved labels for super-resolution bioimaging.

Identifiers

PMID40880781
PMCPMC12379806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.